Here's a quick recap of all that inspired us HLTH this year. Creating the future of health as heard from business leaders far and wide. This particular conference gives us a moment to take a pause, immerse in the total health ecosystem and to challenge our thinking about our role in creating what's next. Congrats to Jonathan Weiner for an incredibly successful year 2 of this amazing convention.
Russian Call Girls Kota * 8250192130 Service starts from just âč9999 â
Â
Highlights from HLTH 2019
1. HLTH 2019 | CREATE HEALTHâS FUTURE
OCTOBER 27-26, MGM GRAND LAS VEGAS
2. COPYRIGHT PUBLICIS HEALTH 2019
INSIGHTS AND LEARNINGS FROM
PUBLICIS HEALTH
2
BRENDAN GALLAGHER
Chief Connected Health Officer
Publicis Health Media
CEDRIC DE SAINT HILAIRE
VP, Marketing and Growth Initiatives
Publicis Health
LYN FALCONIO
Chief Marketing Officer
Publicis Health
COLAN MCGEEHAN
Chief Investment Officer
Publicis Health Media
3. ONE OF THE LARGEST
AND MOST IMPORTANT
CONFERENCE FOR HEALTH INNOVATION
7,000+
ATENDEES
300+
SPEAKERS
1000+
CEOs & FOUNDERS
7,500+
1:1 MEETINGS
150+
MEDIA & ANALYSIS
4. COPYRIGHT PUBLICIS HEALTH 2019
âWATCH THAT HOPEFULLY A
HUNDRED YEARS FROM
NOW, IT WILL BE RECORDED
IN HISTORY THAT
WE MADE A DIFFERENCEâ
âBernard Tyson, Kaiser Permanente
4
5. COPYRIGHT PUBLICIS HEALTH 2019
PATIENT ENAGEMENT
TAKES CENTER STAGE
THE TAKE AWAY
Patient-centricity is not a new idea, but amidst shifting consumer expectations and an outcomes
economy, âpatient-centricityâ has taken on fresh meaning. It is paramount for brands to
holistically embrace these expectations and drive engagement across the total healthcare value
chain.
The need for patient-centricity and patient engagement has ripple effects throughout the system
and is not limited to HCPs, patients, or Pharma.
5
THE TALK
Nearly every presentation at HLTH could be tied back to the critical role patient engagement
plays across the healthcare value-chain. We are at the dawn of a new era where the most
successful solutions will be ones that engage patients beyond the point-of-care and towards the
entire healthcare journey.
This âpatient-firstâ call-to-action is the most critical component to the transformation ahead and
the most vital component to better outcomes.
6. COPYRIGHT PUBLICIS HEALTH 2019
PHARMA REIMAGINED
THE TAKE AWAY
ï§ Pharmaceutical companies will continue to play an evolving and increasingly important role in
the larger healthcare ecosystem. Their impact will stretch beyond âthe pillâ and into care
services, digital therapeutics, and more.
ï§ Pharma is well-positioned to leap-frog, leveraging their proximity to customers, new talent,
technologies, and data to develop innovative solutions beyond medication.
6
THE TALK
The Pharmaceutical industry was center stage at HLTH focused on the emerging role they play
in the overall healthcare ecosystem. As Pharma races into the future, they challenged the
perception their industry was slow to change, out of touch, and part of the healthcare problem.
The significant areas of focus for Pharma include:
âą The reinvention of their culture and infrastructure to meet the demands of agility, speed, and
innovation that are essential to the pace of todayâs Life Science industry.
âą The emerging role Chief Digital Officers recruited from outside of Pharma play in reframing
their patient centric approach through the lens of data and technology.
âą The pivot from manufacturing products to manufacturing products plus services.
âą Closing the gaps that create roadblocks to getting new discoveries to market, and in the
hands of patients.
7. COPYRIGHT PUBLICIS HEALTH 2019
DISRUPTIVE COLLABORATION â
THE NEW HEALTH ECOSYSTEM
THE TAKE AWAY
ï§ Partnership closes the gap between âideaâ and âactionâ and accelerates future potential.
ï§ Internal culture shifts and change management struggles are often roadblocks to partnership
and therefore speed and organizational agility.
ï§ The focus should be on rallying internal and external support to implement a partnership as
efficiently as possibleâânail it and scale it.â
7
THE TALK
Collaboration in healthcare is easier said than done. An untamed avalanche of new players,
innovators, products, and technologies are taking the industry by stormâall seeking to stake
claim with their unique IP.
Patient-centricity inherently requires collaboration. While remaining fiercely protective of their
proprietary investments, there was a universal understanding that close collaboration with
external partners is essential to engagement and better outcomes.
âDisruptive collaborationâ was thematic throughout the conference and has become essential to
survive the shifts in the healthcare marketplace.
8. COPYRIGHT PUBLICIS HEALTH 2019
BEHIND EVERY INNOVATION
THERE IS A PERSONAL STORY
THE TAKE AWAY
ï§ The next frontier of engagement will be underpinned by data. We must leverage data
intelligence to find and understand insights that will create pathways for engagement
throughout the healthcare system.
ï§ Lack of data is not the issue; we have more data than ever before. We must transform data
into activation-ready insights.
8
THE TALK
There is nothing more intimately personal than health. Behind some of the most innovative
advancements in medicine are a founderâs personal story, an innovatorâs wake-up call born from
a family experience, or an observation or insight brought to light through a moving patient
encounter.
Unearthing personal, radically relevant insights and motivators will be instrumental in the next
generation of healthcare. In order to find meaningful insights we have to activate the abundance
of data we have and connect it back to people.
9. COPYRIGHT PUBLICIS HEALTH 2019
WOMEN @ HLTH
THE TAKE AWAY
ï§ While gender parity in healthcare has improved, there is opportunity to develop support
systems that bring women into the C-Suite.
ï§ Women HCPs are still largely playing in a male-dominated field, but the tides are changing.
The physician of the future is largely female.
ï§ These shifts create new opportunities for companies to create professional development
opportunities to bring women into leadership roles and improved support systems for
women HCPs.
9
THE TALK
Women now represent 40% of managerial roles in the workforce. They also now surpass men in
rates of higher education and increasingly occupy high-profile professional and political leadership
roles.
In healthcare specifically, the gender parity movement is stronger than ever. Over 30% of
practicing physicians are women, compared to 17% in 1990. For millennial physicians, the
percentage doublesâ60% of physicians under 35 are women.
However, when it comes to the corner office, the glass ceiling still exists. Men still dominate senior
executive positions in healthcare: only 13% are women and only two healthcare companies on the
Fortune Global 500 have female CEOs.
10. COPYRIGHT PUBLICIS HEALTH 2019
OUTCOMES CASTS A
BROADER NET
THE TAKE AWAY
ï§ A keen understanding of the social determinants of health will become standard operating
procedure and fully integrated into patient EHRs.
ï§ This shift will change the way companies and hospital systems interact with communities.
These organizations are moving from community benefit to community healthâinvesting in a
community enterprise to drive better outcomes.
10
THE TALK
Publicis Health has long recognized the importance of the âtotal treatment effectâ. It is the
understanding that better outcomes come from a confluence of factors beyond the prescription,
including: your personal beliefs, your mindset, your behaviors, and even your zip code.
The âtotal treatment effectâ is essential to understand because it changes how we will treat
patients in the future. Physician referrals will extend beyond a traditional connection and into fully
integrated care, including community resources, advocacy networks, social influencers, and at-
home support networks.
11. COPYRIGHT PUBLICIS HEALTH 2019
POINT OF CARE MOVES OUT
OF OFFICE
THE TAKE AWAY
ï§ We are at the cusp of reinventing where we receive our care, but still stuck in a system
designed for us to go to care versus care coming to us.
ï§ The entire ecosystemâincluding payerâneeds to be addressed. For example, until last year
it was Medicare fraud if a patient was not physically examined by an HCP.
ï§ Technology isnât the problemâour system is the issue. We have to change the fracture at the
center of the system in order to experience the advantage of innovation and emerging
technology.
THE TALK
Telehealth is at a tipping point, concierge care is popping up in many urban areas, Walmartâs
health and wellness centers will fill access deserts, and Amazonâs Alexa is giving us voice care
at home.
One of the most discussed topics at HLTH was the mounting frustrations of having the
technology and vision to enable care at home, while being locked into a 19th century model of
institutional care. In every other part of modern life technology has enabled greater connectivity
and reduced burdens across the board. Yet in health, if youâre sick, you have to bounce between
facilities where there may be over 100 EMRs.
12. COPYRIGHT PUBLICIS HEALTH 2019
UNLOCKING VOICE
THE TAKE AWAY
ï§ Voice will be a critical new interface for health engagementâboth with Patients and HCPs.
ï§ Brands alone will find it difficult to be of true value without seamlessly passing language data
between partners and systems.
ï§ As Voice Biometrics continues to emerge, look for completely new paradigms in disease
detection, identity management, and personalization based on unique Voice attributes.
12
THE TALK
âVoice in Healthâ was another huge themeâwith an entire track dedicated to it. Missy Krasner
from Amazon reminded us during one session that while still early, the beta program for HIPAA-
compliant skills has been a huge success.
The new HIPPA-compliant environment from Amazonâs Alexa allows consumers to check on
prescription orders, schedule appointments, and even check-in with their care teams via voice.
Beyond these modern conveniences, these in-home devices can detect subtle changes in
behavior, breathing, sleep patterns, and movementâallowing care providers to more accurately
hear the signals early to prompt intervention
Leaders from Livongo and Atrium Health showcased their beta skills to a crowd eager for actual
use cases for Voice in Health. Orbita.ai President and COO Nate Treloar, referenced a study
they did in collaboration with Voicebot.ai that shows more than half of consumers want to use a
Voice Assistant for Healthcare.
13. COPYRIGHT PUBLICIS HEALTH 2019
BALANCING HIGH TECH AND
HIGH TOUCH
THE TAKE AWAY
ï§ When balancing tech and touch, itâs important to address a broader responsibility tooâ
ensuring that each new tech innovation is built with the level of scientific rigor and accuracy
our industry demands.
ï§ There are concerns that certain technologies might be more hype. Credibility, responsibility,
and integrity must lead future innovation.
13
THE TALK
The general consensus is they do not have to be mutually exclusive. The human element has
always beenâand will continue to beâan essential aspect of patient care. Tech will allow us to
more appropriately allocate who needs attention versus those that donât. If put to the right use,
we will be able to better identify those who need human intervention and others who do not.
Moreover, if leveraged correctly, technology can open the gateway to more high touch
interactions. The more we leverage new care technologies, the more we allow human touch to
get back to care and away from administrative burden.
14. COPYRIGHT PUBLICIS HEALTH 2019
THE DEMOCRATIZATION OF
DATA
THE TAKE AWAY
ï§ We need activation-ready insights from the data that enable us to build support tools for both
physicians and their patients.
ï§ Data-driven, personalized care pathways will shape new decision making and a new level of
engagement between physicians, patients, and caregivers.
ï§ Itâs challenging for doctors to keep up in this changing landscape. There is a gap between
truly innovative discoveries and getting physicians and patients educated to take advantage of
them.
14
THE TALK
The explosion of personal data has rippled across all of healthcare and will impact almost every
acute and chronic condition. The power of intelligent computing to help automate precise,
personalized care is game-changing for patients and physicians alike. One of the most
fascinating places to see the capabilities of data and AI come to life is in oncology.
From breakthrough genomic discoveries, to the advanced technologies that can match you, your
specific cancer type, and your specific gene mutation to available products that have the highest
treatment successâprecision care will unlock future outcomes.
15. COPYRIGHT PUBLICIS HEALTH 2019
HEALTHâS 5 STAR SERVICE
THE TAKE AWAY
ï§ New tools, channels, communications, and services will be adopted in order to re-engage
patients where and how they want to.
ï§ Technology and virtual care can offer the power to be in touch with people at moments that
matter to them. These tools have the power to re-engage patients with both reactive and
preventative care.
15
THE TALK
âQuality serviceâ in any industry is subjective and in healthcare quality for patients could mean
easier access, expedient service, and lower costs. The larger marketplace informs patient
expectations when it comes to quality of care. Consumers are used to having multiple options
and getting what they want when and where they want it. However, the healthcare industry
hasnât caught up.
This lag means that in some cases, patients arenât engaging with healthcare at all. Access to
new care models (telemedicine, point solutions, etc.) must be accelerated to provide the range of
services consumers expect.
16. COPYRIGHT PUBLICIS HEALTH 2019
RETAIL, CPG, PHARMACY,
AND MARK CUBAN
THE TAKE AWAY
ï§ Combined services is the future. When physician and pharmacists are in the same place, the
impact on filling your Rx and getting a jump start on adherence is off to the right start.
ï§ The accessibility of healthcare will continue to be a focal point in order to meet shifting
consumer demands. Convenience, on demand, and âone stopâ shops for services,
medication, nutrition, and more, will become increasingly important.
16
THE TALK
The players in healthcare have expanded in recent years with companies like Walmart, Bose,
Mastercard, Walgreens, CVS, Best Buy, Samsung, AT&T and a host of others anchoring their
roles in health and wellness. Retail in Health was a big themeâwith both the CEO of CVS
Health, Larry Merlo, and Marcus Osborne VP Health & Wellness at Walmart doing back-to-back
General Sessions (the BIG stage).
Larry mapped out a few innovations CVS is planning, including at-home dialysis, and Marcus
walked through the new Walmart Health Superstore in Dallas, Georgia. The supercenter was
impressive with full primary care services, dental, vision, wellness classes and more, including
staying open for late hours and weekends for better community access.
Mark Cuban took center stage with an announcement that he is entering health. He brought a
total re-imagination to how fixing our systems nationwide.
17. COPYRIGHT PUBLICIS HEALTH 2019
TABLE TALK
THE TAKE AWAY
ï§ The road to a better Healthcare System is paved with problems requiring a diverse set of
experiences and skillsets. Find a set of partners and tackle the problems you can one at a time.
ï§ The hope for a government-led systemic change in the US Healthcare system is thin amongst
those in the system itself. Donât wait for change to happenâbe the change.
17
THE TALK
Mornings started early at HLTH with 7:30am âTable Talksââwhere people from across different
industries get together and discuss pre-determined topics.
Publicis Health joined a discussion on âAddressing the Challenges of Patient Adherence,â
combined with the âChallenges of Digital Health Integration.â Attendees included Click
Therapeutics, Aetna, CVS, AI-startup Prealizer, NovoNordisk, Integrated Medication Management,
and Healthpartners.
Topics discussed:
ï§ The difference between clinical trial and real-world data in studies with insulin (Hint, the real-world
doesnât have all the guidance)
ï§ The near-term potential of AI in drug discovery
ï§ What will each of our companies be able to be most proud of in 10 years?
ï§ The role of better engagement across the industry
18. COPYRIGHT PUBLICIS HEALTH 2019
THE INTEROPERABILITY
DEBATES
THE TAKE AWAY
ï§ Blockchain may represent the key to owning your own Health data, but is still a ways out.
ï§ New Interoperability standards may be a more near-term solution to building better, more
connected healthcare experiences. Brands should begin to explore opportunities to become a
more meaningful contributor to overall patient outcomes by partnering with systems where
healthcare happens.
18
THE TALK
With representatives from both the executive branch of the Federal government (Don Rucker,
National Coordinator for Health Information Technology) and Google Cloud (Aashima Gupta,
Director, Global Healthcare Solutions), the heated debate spanned the role of government and
free markets, how we got here as a system, and what is the path forward.
When asked what he would say if Mark Zuckerberg announced that as an addition to Libra,
Facebookâs proposed permissioned Blockchain digital currency, they would incorporate a coin-
based patient health record on their platform, John Bass, Founder & CEO of Hashed Health,
said, âThatâs like inviting Hannibal Lecter over to your house to meet your kid.â
19. COPYRIGHT PUBLICIS HEALTH 2019
HOW WILL HISTORY
RECORD US?
THE TAKE AWAY
His call to action:
Working together, let us be the leaders recorded in history that made a difference.
19
THE TALK
While every track and session at HLTH explored important topics that are unlocking what the
future will hold for health, it was probably CEO of Kaiser Permanente, Bernard Tyson, that
moved audiences most.
He posed the provocative question: âin 40 years how will history record what we did on our
watch?â He asked, did we accept that in one of the wealthiest countries so many people donât
have a home? Did we accept that we waste more food than would be enough to feed every
citizen in this country but did nothing to ensure nutrition was on the table for everyone? Did we
accept that, last year alone, 44,000 people took their own lives while knowing that our mental
health programs are inadequate? Did we accept that we did not fix a broken system that severs
the head from the rest of the body?
20. COPYRIGHT PUBLICIS HEALTH 2019
IN SUMMARY
20
The HLTH Conference was a powerful gathering that showcased the companies, trends, and
leaders that are shaping the future of health. The common thread throughout the conference was
patient-centricity and how the products, services, and technology designed for patients will drive
engagement, better outcomes, and healthier people.
At Publicis Health our portfolio of companies brings unique solutions to achieve radical patient-
centricity across the healthcare engagement value-chain. Driven by one purpose, we bring
together data, technology and creativity to create solutions for people to be equipped and
motivated to take control of their health.
HLTH GENERAL SESSION
VIDEO SUMMS UP THE
OPPORTUNITIES AHEAD
âInnovation and change are not a natural state. Status quo is a very powerful current.â potentially?
connversation with a patient based on their social status is a very new idea which is very sensitive and requires a lot of education on all ends, including patients to understand why we are asking them certain questions.
Another challenge that we face in this industry is the connection between the communities that may not be part of the equation. .
Fully integrating these dimensions but also understanding that everyone is concerned with these social determinants is a critical component,
Reinventing care to the home. We are the cusp of transferring more care to the home. Itâs a trifecta win. Help patients, lower costs and help doctors.
Â
We are still locked into a 19th century model locked into institutional care. We have the tech to go home, but are locked in an old system. Too much care is done in hospitals and nursing homes.
Â
The face to face experience has not changed. Up until last year it was Medicare fraud if you did not personally examine that patient yourself.
Today we still ask people to come to medicine versus us going to them. If you are sick you have to bounce between facilities, there are over 100 EMRs. There is fracture at the center of innovation.
Â
75% of hospital readmissions are preventable.
Design a new system to put more care at home.
Still rely on 19th and 20th century technologies. What we need to get right is hands on care.
How comfortable are you at taking care of a patient you donât actually see.
Better care to more people at a fraction of a cost.
One of the fastest growing mortality risks is visiting the hospital.
In every other part of our lives tech has caused connectivity and reducing burdens. Tech makes things easier everywhere else.
Â
The intersection of digital health and personalized medicine?
Democratization of Cancer Care
3 core things:
the impact of intelligence computing to help automate care
Sharing information and sharing data
Security, privacy and safety
Â
What does the future look like, what can we leave excited about as it relates to cancer care
Notable Labs â take blood sample from a patient and test thousands of drugs on those cancer cells. Showing 84% accuracy on whether a particular patient would benefit from that therapy.
IBM Watson â expansion of state of the art care. But itâs not easy keeping up with it. Explosion of data. Very hard to keep up. Requies a lot of data and time to keep up with the
Leverage tech to provide decision support. Physicians are still autonomous but they are given the tools to better make decisions â care pathways, genomics, and whatâs available to their profession
âCancer is moving from a disease of the organs to a disease of the genomeâ Foundation Medicine is in the business of transforming Cancer Care. Info and reports that details the underlying genomic drivers and products that are available. If products are not available it will match them to clinical trials targeted to their gene mutation.
Work w/ pharma to develop products very early on
Â
Precision therapies. Still people are only looking at one genomic driver versus multiple.
W precision medicine we now have opportunity of identifying who will respond.
There is some over-exuberance on the part of patients, because still less than 10% of pitients w/ advanced cancer are eligible for these precision drugs
Dr.s also donât order the swquencing all the time. Some times access is inequitable. It is an exciting time but also still many hurdles.
How is real world data used in democratization of cancer â very exciting in realm in clinical trials.
Where are we 5 years from now:
Better understand drivers of carcinogenesis
Provide decision support to help phyicians aware of when they should order genetic sequencing
Patients need to be empowered to understand when they need genetirc sequencing
Move the use from metastic setting to prevention and early dedection
Decision support that physicians need at the point of care
Democratization of data to really inform their treatment decisions
We learn from every patient to build a map over time
Can get to a point where doctor says â we evaluated your personal data and here are the 5 medicines that we will give you and here is their probability of successâ
Is the patient really equipped to participate and make these decisions?
Â
Decision support at point of care
Reports from next generation sequencing that are actionable
we have captured the interest of patients â there is an exciting movement driven by patients
Â
Â
Democratization of Cancer Care
3 core things:
the impact of intelligence computing to help automate care
Sharing information and sharing data
Security, privacy and safety
Â
What does the future look like, what can we leave excited about as it relates to cancer care
Notable Labs â take blood sample from a patient and test thousands of drugs on those cancer cells. Showing 84% accuracy on whether a particular patient would benefit from that therapy.
IBM Watson â expansion of state of the art care. But itâs not easy keeping up with it. Explosion of data. Very hard to keep up. Requies a lot of data and time to keep up with the
Leverage tech to provide decision support. Physicians are still autonomous but they are given the tools to better make decisions â care pathways, genomics, and whatâs available to their profession
âCancer is moving from a disease of the organs to a disease of the genomeâ Foundation Medicine is in the business of transforming Cancer Care. Info and reports that details the underlying genomic drivers and products that are available. If products are not available it will match them to clinical trials targeted to their gene mutation.
Work w/ pharma to develop products very early on
Â
Precision therapies. Still people are only looking at one genomic driver versus multiple.
W precision medicine we now have opportunity of identifying who will respond.
There is some over-exuberance on the part of patients, because still less than 10% of pitients w/ advanced cancer are eligible for these precision drugs
Dr.s also donât order the swquencing all the time. Some times access is inequitable. It is an exciting time but also still many hurdles.
How is real world data used in democratization of cancer â very exciting in realm in clinical trials.
Where are we 5 years from now:
Better understand drivers of carcinogenesis
Provide decision support to help phyicians aware of when they should order genetic sequencing
Patients need to be empowered to understand when they need genetirc sequencing
Move the use from metastic setting to prevention and early dedection
Decision support that physicians need at the point of care
Democratization of data to really inform their treatment decisions
We learn from every patient to build a map over time
Can get to a point where doctor says â we evaluated your personal data and here are the 5 medicines that we will give you and here is their probability of successâ
Is the patient really equipped to participate and make these decisions?
Â
Decision support at point of care
Reports from next generation sequencing that are actionable
we have captured the interest of patients â there is an exciting movement driven by patients
Â
Â
Democratization of Cancer Care
3 core things:
the impact of intelligence computing to help automate care
Sharing information and sharing data
Security, privacy and safety
Â
What does the future look like, what can we leave excited about as it relates to cancer care
Notable Labs â take blood sample from a patient and test thousands of drugs on those cancer cells. Showing 84% accuracy on whether a particular patient would benefit from that therapy.
IBM Watson â expansion of state of the art care. But itâs not easy keeping up with it. Explosion of data. Very hard to keep up. Requies a lot of data and time to keep up with the
Leverage tech to provide decision support. Physicians are still autonomous but they are given the tools to better make decisions â care pathways, genomics, and whatâs available to their profession
âCancer is moving from a disease of the organs to a disease of the genomeâ Foundation Medicine is in the business of transforming Cancer Care. Info and reports that details the underlying genomic drivers and products that are available. If products are not available it will match them to clinical trials targeted to their gene mutation.
Work w/ pharma to develop products very early on
Â
Precision therapies. Still people are only looking at one genomic driver versus multiple.
W precision medicine we now have opportunity of identifying who will respond.
There is some over-exuberance on the part of patients, because still less than 10% of pitients w/ advanced cancer are eligible for these precision drugs
Dr.s also donât order the swquencing all the time. Some times access is inequitable. It is an exciting time but also still many hurdles.
How is real world data used in democratization of cancer â very exciting in realm in clinical trials.
Where are we 5 years from now:
Better understand drivers of carcinogenesis
Provide decision support to help phyicians aware of when they should order genetic sequencing
Patients need to be empowered to understand when they need genetirc sequencing
Move the use from metastic setting to prevention and early dedection
Decision support that physicians need at the point of care
Democratization of data to really inform their treatment decisions
We learn from every patient to build a map over time
Can get to a point where doctor says â we evaluated your personal data and here are the 5 medicines that we will give you and here is their probability of successâ
Is the patient really equipped to participate and make these decisions?
Â
Decision support at point of care
Reports from next generation sequencing that are actionable
we have captured the interest of patients â there is an exciting movement driven by patients
Â
Â